| GTO ID | GTC3371 |
| Trial ID | NCT05775666 |
| Disease | Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UCLM802 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | UCLM802-Ⅰ |
| Cohort 1 | |||||||||||
|
|||||||||||